As the immune response approaches zero, there is a point at which immune suppression becomes impossible at any cancer level, and the optimal control transitions to an initial high dose treatment followed by an indefinite maintenance treatment; this is associated with the majority of the cancer cell population becoming CD38 negative. Here, CD38 is linked to cancer.